Arax Capital Partners logo

Arax Capital Partners

Europe, Wien, Austria, Vienna

Description

ARAX Capital Partners provides Seed and early stage investments to Austrian biotech and hightech startups

Investor Profile

Arax Capital Partners has made 40 investments, with 1 in the past 12 months and 10% as lead.

Stage Focus

  • Series Unknown (75%)
  • Seed (15%)
  • Series A (5%)
  • Convertible Note (3%)
  • Series B (3%)

Country Focus

  • Austria (80%)
  • United States (20%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Information Technology
  • Software
  • Manufacturing
  • Semiconductor
  • Logistics
  • Rfid
  • Wireless
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Arax Capital Partners frequently co-invest with?

PV
Europe, Wien, Austria, Vienna
Co-Investments: 1
4SC
Europe, Bayern, Germany, Planegg
Co-Investments: 1
Pi Labs
Europe, England, United Kingdom, London
Co-Investments: 1
Kinled Holding
North America, New York, United States, New York
Co-Investments: 1
aws Gründungsfonds
Europe, Wien, Austria, Vienna
Co-Investments: 2
EF
Europe, Oppland, Norway, Gjøvik
Co-Investments: 1
Peak Pride
Europe, Wien, Austria, Vienna
Co-Investments: 1
Conor Venture Partners
Europe, Southern Finland, Finland, Espoo
Co-Investments: 1
NV
Europe, Oslo, Norway, Oslo
Co-Investments: 1
MIG Capital
Europe, Bayern, Germany, München
Co-Investments: 2

What are some of recent deals done by Arax Capital Partners?

Greenpass

Vienna, Wien, Austria

Greenpass is a SaaS platform for climate resilient urban planning and architecture that enables livable cities.

ArchitectureCleanTechSaaS
SeedSep 24, 2024
Calyxha Biotechnologies GmbH

Vienna, Wien, Austria

Calyxha is developing novel therapies targeting tissue degeneration that is the fundamental underlying cause of major human diseases.

BiotechnologyClinical TrialsMedical
SeedFeb 28, 2020
Amount Raised: $1,102,739
EveliQure Biotechnologies GmbH

Vienna, Wien, Austria

EveliQure was founded in 2012 with headquarters in Vienna and developed for the first time a combined vaccine.

Life Science
Series AJul 1, 2019
Amount Raised: $2,821,874
The MoonVision

Vienna, Wien, Austria

The MoonVision is an efficient visual object recognition plattform for your business.

Artificial Intelligence (AI)Information ServicesInformation TechnologyMachine LearningSoftware
SeedJan 31, 2019
Amount Raised: $686,890
crystalsol

Vienna, Wien, Austria

Crystalsol is a technological company that focusses on developing a new type of flexible photovoltaic technology.

Renewable EnergySemiconductorSolarSustainability
Series UnknownDec 31, 2016
Amount Raised: $599,785
Airborne Robotics

Klagenfurt, Karnten, Austria

AIRBORNE ROBOTICS develops, builds and distributes flight robots (drones) for industrial applications and professional cinematic tasks.

Drones
Series UnknownSep 16, 2016
IDENTEC SOLUTIONS

Addison, Texas, United States

Identec Solutions provides RFID-based solutions to improve productivity and safety in harsh environments

Information TechnologyLogisticsManufacturingRFIDSoftwareWireless
Series UnknownJun 30, 2016
Amount Raised: $610,501
AFFiRiS

Gerasdorf Bei Wien, Niederosterreich, Austria

AFFiRiS develops tailor-made peptide vaccines for alzheimer's, parkinson's, atheroclerosis, hypertension and several other conditions.

BiotechnologyMedicalPharmaceutical
Series UnknownJun 28, 2016
Amount Raised: $10,000,000

CONDA is Full-service Crowdinvesting-Platform to boost up Austrian StartUps

BlockchainCrowdfundingFinancial ServicesFinTech
Series UnknownDec 31, 2015
Amount Raised: $271,456
crystalsol

Vienna, Wien, Austria

Crystalsol is a technological company that focusses on developing a new type of flexible photovoltaic technology.

Renewable EnergySemiconductorSolarSustainability
Series UnknownDec 31, 2015
Amount Raised: $1,493,006